Evidence map›Paper›PMID 32868971›Full record

ArticleSaudi journal of biological sciences2021

Exploring optical spectroscopic techniques and nanomaterials for virus detection.

Sello Lebohang Manoto, Ahmed El-Hussein, Rudzani Malabi, Lebogang Thobakgale, Saturnin Ombinda-Lemboumba, Yasser A Attia, Mohamed A Kasem, Patience Mthunzi-Kufa

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sello Lebohang ManotoCouncil for Scientific and Industrial Research (CSIR), National Laser Centre, P.O. Box 395, Pretoria 0001, South Africa.
Ahmed El-HusseinNational Institute of Laser Enhanced Science, Cairo University, Egypt.
Rudzani MalabiCouncil for Scientific and Industrial Research (CSIR), National Laser Centre, P.O. Box 395, Pretoria 0001, South Africa.
Lebogang ThobakgaleCouncil for Scientific and Industrial Research (CSIR), National Laser Centre, P.O. Box 395, Pretoria 0001, South Africa.
Saturnin Ombinda-LemboumbaCouncil for Scientific and Industrial Research (CSIR), National Laser Centre, P.O. Box 395, Pretoria 0001, South Africa.
Yasser A AttiaNational Institute of Laser Enhanced Science, Cairo University, Egypt.
Mohamed A KasemNational Institute of Laser Enhanced Science, Cairo University, Egypt.
Patience Mthunzi-KufaCouncil for Scientific and Industrial Research (CSIR), National Laser Centre, P.O. Box 395, Pretoria 0001, South Africa.
Council for Scientific and Industrial Research · ZACairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral infections pose significant health challenges globally by affecting millions of people worldwide and consequently resulting in a negative impact on both socioeconomic development and health. Corona virus disease 2019 (COVID-19) is a clear example of how a virus can have a global impact in the society and has demonstrated the limitations of detection and diagnostic capabilities globally. Another virus which has posed serious threats to world health is the human immunodeficiency virus (HIV) which is a lentivirus of the retroviridae family responsible for causing acquired immunodeficiency syndrome (AIDS). Even though there has been a significant progress in the HIV biosensing over the past years, there is still a great need for the development of point of care (POC) biosensors that are affordable, robust, portable, easy to use and sensitive enough to provide accurate results to enable clinical decision making. The aim of this study was to present a proof of concept for detecting HIV-1 pseudoviruses by using anti-HIV1 gp41 antibodies as capturing antibodies. In our study, glass substrates were treated with a uniform layer of silane in order to immobilize HIV gp41 antibodies on their surfaces. Thereafter, the HIV pseudovirus was added to the treated substrates followed by addition of anti-HIV gp41 antibodies conjugated to selenium nanoparticle (SeNPs) and gold nanoclusters (AuNCs). The conjugation of SeNPs and AuNCs to anti-HIV gp41 antibodies was characterized using UV-vis spectroscopy, transmission electron microscopy (TEM) and zeta potential while the surface morphology was characterized by fluorescence microscopy, atomic force microscopy (AFM) and Raman spectroscopy. The UV-vis and zeta potential results showed that there was successful conjugation of SeNPs and AuNCs to anti-HIV gp41 antibodies and fluorescence microscopy showed that antibodies immobilized on glass substrates were able to capture intact HIV pseudoviruses. Furthermore, AFM also confirmed the capturing HIV pseudoviruses and we were able to differentiate between substrates with and without the HIV pseudoviruses. Raman spectroscopy confirmed the presence of biomolecules related to HIV and therefore this system has potential in HIV biosensing applications.

Indexed as

Anti-HIV gp41 antibodiesBiosensingHuman immunodeficiency virus (HIV)Nanomaterials

Identifiers

PMID32868971
PMCPMC7449958
OpenAlexW3081290805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.